Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage

Brain Research

Volumn 818, Issue 2, 1999, Pages 221-227

  Mayo, Juan Carlos ^a   Sainz, Rosa Maria ^a   Antolín, Isaac ^a   Rodriguez, Carmen ^a  

^a Fac Med Julian Claveria S ^*  (Spain)

Author keywords

6 hydroxydopamine; Apoptosis; Electron microscopy; Melatonin; Necrosis; PC12 cell

Indexed keywords

MELATONIN; OXIDOPAMINE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; MELATONIN; MICROSCOPY, ELECTRON; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; PC12 CELLS; RATS;

EID: 0033550706     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01262-1     Document Type: Article

References (23)

1. Antolín I., Rodríguez C., Sainz R.M., Mayo J.C., Uría H., Kotler M., Rodríguez-Colunga M.J., Tolivia D., Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10:1996;882-890.
2. Cathapermal S., Lavigne M.C., Leong-Son M., Alibadi T., Ramwell P.W. Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17beta-estradiol is estrogen receptor dependent. J. Cardiovasc. Pharmacol. 31:1998;499-505.
3. Chuang J.I., Mohan N., Meltz M.L., Reiter R.J. Effect of melatonin on NF-kappa B DNA-binding activity in the rat spleen. Cell. Biol. Int. 20:1996;687-692.
4. Cohen G., Heikkila R. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 250:1974;2447-2452.
5. Gilad E., Wong H.R., Zingarelli B., Virag L., O'Connor M., Salzman A.L., Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappa B activation. FASEB J. 12(685):1998;693-700.
6. Green L., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
7. Lezoualc'h F., Sparapani M., Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. J. Pineal Res. 24:1998;168-178.
8. Mayo J.C., Sainz R.M., Uría H., Antolín I., Esteban M.M., Rodríguez C. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J. Pineal Res. 24:1998;179-192.
9. Michel P.P., Hefty F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:1990;428-435.
10. Molis T.M., Walters M., Hill S.M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int. J. Oncol. 3:1993;687-696.
11. Reiter R.J. Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Clin. Exp. Res. 7:1995;340-351.
12. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:1995;526-533.
13. Reiter R.J. Antioxidant actions of melatonin. Adv. Pharmacol. 38:1997;103-117.
14. Reiter R.J., Melchiorri D., Sewrynek E., Poeggeler B., Barlow-Walden L., Chuang J., Ortiz G.G., Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
15. Reynolds E.S. The use of the lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell. Biol. 17:1963;208-212.
16. Roy A.K., Vellanoweth R.L., Chen S., Supakar P.C., Jung M.H., Song C.S., Chatterjee B. The evolutionary tangle of aging, sex, and reproduction and an experimental approach to its molecular dissection. Exp. Gerontol. 31:1996;83-94.
17. Ryter A., Kellenberger E., Birch-Anderson A., Maaløe O. Etude au microscope électronique de plasmas contenant de l'acide désoxyribonucléique. Z. Naturforscg. 13:1958;597-602.
18. Sainz R.M., Mayo J.C., Uría H., Kotler M., Antolín I., Rodríguez C., Menendez-Pelaez A. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 19:1995;178-188.
19. Schwartz A.G., Pashko L.L. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. J. Cell. Biochem. Suppl. 22:1995;210-217.
20. Sergeev I.N., Arkhapchev I.P., Spirichev V.B. The role of vitamin E in metabolism and reception of vitamin D. Biokhimiia. 55:1990;1989-1995.
21. Tan D.X., Poeggeler B., Reiter R.J., Chen L.D., Chen S., Manchester L.C., Barlow-Walden L.R. The pineal hormone melatonin inhibits DNA adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:1993;65-71.
22. Walkinshaw G., Waters C.M. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 63:1994;975-987.
23. Zigmond M.J., Striker E.M. Animal models of Parkinsonism using selective neurotoxins: clinical and basic implications. Int. Rev. Neurobiol. 31:1989;1-79.